The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 27, 2019

Filed:

Dec. 07, 2015
Applicant:

The Procter & Gamble Company, Cincinnati, OH (US);

Inventors:

Janette Villalobos Lingoes, Cincinnati, OH (US);

Thomas Elliot Rabe, Baltimore, MD (US);

Grant Edward Anders Striemer, Fairfield Township, OH (US);

Robert Ha, Liberty Township, OH (US);

Denny Eugene Kuhlman, Liberty Township, OH (US);

Assignee:

The Procter & Gamble Company, Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/02 (2006.01); A61K 8/04 (2006.01); A61Q 1/02 (2006.01); A61K 8/81 (2006.01); A61K 8/29 (2006.01); A61K 8/19 (2006.01); A61K 8/86 (2006.01); A61K 8/34 (2006.01); A45D 44/00 (2006.01); B41J 2/21 (2006.01); A45D 34/04 (2006.01);
U.S. Cl.
CPC ...
A61K 8/0241 (2013.01); A45D 34/04 (2013.01); A45D 44/00 (2013.01); A61K 8/044 (2013.01); A61K 8/19 (2013.01); A61K 8/29 (2013.01); A61K 8/345 (2013.01); A61K 8/8147 (2013.01); A61K 8/8152 (2013.01); A61K 8/8182 (2013.01); A61K 8/86 (2013.01); A61Q 1/02 (2013.01); B41J 2/2107 (2013.01); A45D 2044/007 (2013.01); A61K 2800/26 (2013.01); A61K 2800/412 (2013.01); A61K 2800/43 (2013.01); A61K 2800/5424 (2013.01); A61K 2800/592 (2013.01); A61K 2800/594 (2013.01); A61K 2800/621 (2013.01); A61K 2800/805 (2013.01); A61K 2800/87 (2013.01);
Abstract

A treatment composition for, among other things, treating human skin. These compositions are stable, particulate containing, printer compositions that have one or more particulate suspending agents. The suspending agents can be present in a concentration of from about 0.1% to about 5%, by weight. The particles in the particulate composition have a combined Particle Size Distribution D50 in the range of about 200 ηm to about 500 ηm, and preferably the compositions have a zeta potential of negative 20 or less, or greater than positive 20. The particulate suspending agent is preferably a polyacrylate composition, even more preferably sodium polyacrylate. The particles can be present in a concentration of from about 1% to about 30.0%, by weight, and preferably the particles in the particulate composition have a combined Particle Size Distribution D90 of less than about 1 μm. The particulate compositions may contain TiOparticles and a second particulate composition which is an iron oxide based colorant particulate composition, another colorant particulate composition, or both.


Find Patent Forward Citations

Loading…